CarsonAllaria Wealth Management, Ltd. - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 61 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
CarsonAllaria Wealth Management, Ltd. ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q2 2022$0–20.0%0.00%–
Q1 2022$0–20.0%0.00%–
Q4 2021$0–2–0.00%–
 Download
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
AJ WEALTH STRATEGIES, LLC 36,001$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders